The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome

Pediatric Research

Volumn 61, Issue 1, 2007, Pages 123-128

  Fernandez, Gabriela C ^a,d   Gomez, Sonia A ^a   Ramos, Maria V ^a   Bentancor, Leticia V ^a   Fernandez Brando, Romina J ^a   Landoni, Veronica I ^a   Lopez, Laura ^c   Ramirez, Flavia ^c   Diaz, Mario ^c   Alduncin, Marta ^b   Grimoldi, Irene ^b   Exeni, Ramon ^b   Isturiz, Martin A ^a   Palermo, Marina S ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b Pediatric Municipal Hospital of San Justo   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BLOOD TRANSFUSION; CELL DEATH; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS; DISEASE SEVERITY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; KIDNEY DYSFUNCTION; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS;

CHILD, PRESCHOOL; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; NEUTROPHILS; PROGNOSIS;

EID: 33846964178     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000250037.47169.55     Document Type: Article

References (44)

1. Remuzzi G, Ruggenenti P 1995 The hemolytic uremic syndrome. Kidney Int 48:2-19
2. Kaplan BS, Meyers KE, Schulman SL 1998 The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9:1126-1133
3. Paton JC, Paton AW 1998 Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450-479
4. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR 1997 Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11:156-160
5. de Jong M, Monnens L 1988 Haemolytic-uraemic syndrome: a 10-year follow-up study of 73 patients. Nephrol Dial Transplant 3:379-382
6. Siegler RL, Milligan MK, Burningham TH, Christofferson RD, Chang SY, Jorde LB 1991 Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J Pediatr 118:195-200
7. Huseman D, Gellermann J, Vollmer I, Ohde I, Devaux S, Ehrich JH, Filler G 1999 Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 13:672-677
8. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET 1973 The hemolytic-uremic syndrome. Nephron 11:174-192
9. Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM 1992 Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 6:50-53
10. Milford D, Taylor CM, Rafaat F, Halloran E, Dawes J 1989 Neutrophil elastases and haemolytic uraemic syndrome. Lancet 2:1153
11. Robson WL, Fick GH, Wilson PC 1988 Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome. Child Nephrol Urol 9:203-207
12. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM 1992 Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42:951-956
13. van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA 1998 Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res 43:759-767
14. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA 2000 The neutrophil as a cellular source of chemokines. Immunol Rev 177:195-203
15. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA 1990 Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171:1155-1162
16. Huber AR, Kunkel SL, Todd RF 3rd, Weiss SJ 1991 Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102
17. Kettritz R, Gaido ML, Haller H, Luft FC, Jennette CJ, Falk RJ 1998 Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 53:84-91
18. Weiss SJ 1989 Tissue destruction by neutrophils. N Engl J Med 320:365-376
19. Lentsch AB, Ward PA 2000 Regulation of inflammatory vascular damage. J Pathol 190:343-348
20. Borregaard N, Cowland JB 1997 Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521
21. Fernandez GC, Gomez SA, Rubel CJ, Bentancor LV, Barrionuevo P, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS 2005 Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr Nephrol 20:1306-1314
22. Boyum A 1968 Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl 97:7
23. Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N 1994 Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 153:1254-1263
24. Whyte MK, Meagher LC, MacDermot J, Haslett C 1993 Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150:5124-5134
25. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J 1994 Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 10:148-153
26. Malazdrewich C, Ames TR, Abrahamsen MS, Maheswaran SK 2001 Pulmonary expression of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-8 in the acute phase of bovine pneumonic pasteurellosis. Vet Pathol 38:297-310
27. Rollet-Labelle E, Grange MJ, Elbim C, Marquetty C, Gougerot-Pocidalo MA, Pasquier C 1998 Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med 24:563-572
28. Lundqvist-Gustafsson H, Bengtsson T 1999 Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils. J Leukoc Biol 65:196-204
29. Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N 1995 Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 154:4157-4165
30. Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel CJ, Palermo MS, Isturiz MA 2003 The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo. Scand J Immunol 57:221-228
31. Bazil V, Strominger JL 1991 Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567-1574
32. Fernandez GC, Rubel C, Barrionuevo P, Lopez L, Ramirez F, Diaz M, Isturiz MA, Palermo MS 2002 Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Pediatr Nephrol 17:337-344
33. Kaplan BS, Mills M 1988 Elevated serum elastase and alpha-1-antitrypsin levels in hemolytic uremic syndrome. Clin Nephrol 30:193-196
34. Wright DG 1988 Human neutrophil degranulation. Methods Enzymol 162:538-551
35. Lew PD, Monod A, Waldvogel FA, Dewald B, Baggiolini M, Pozzan T 1986 Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils. J Cell Biol 102:2197-2204
36. Mori Y, Wada H, Okugawa Y, Tamaki S, Nakasaki T, Watanabe R, Gabazza EC, Nishikawa M, Minami N, Shiku H 2001 Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Clin Appl Thromb Hemost 7:5-9
37. Nevard CH, Jurd KM, Lane DA, Philippou H, Haycock GB, Hunt BJ 1997 Activation of coagulation and fibrinolysis in childhood diarrhoea- associated haemolytic uraemic syndrome. Thromb Haemost 78:1450-1455
38. Tarr PI, Gordon CA, Chandler WL 2005 Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086
39. Fong JS, Kaplan BS 1982 Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion". Blood 60:564-570
40. Walters MD, Levin M, Smith C, Nokes TJ, Hardisty RM, Dillon MJ, Barratt TM 1988 Intravascular platelet activation in the hemolytic uremic syndrome. Kidney Int 33:107-115
41. Luu NT, Rainger GE, Nash GB 1999 Kinetics of the different steps during neutrophil migration through cultured endothelial monolayers treated with tumour necrosis factor-alpha. J Vasc Res 36:477-485
42. Litalien C, Proulx F, Mariscalco MM, Robitaille P, Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E 1999 Circulating inflammatory cytokine levels in hemolytic uremic syndrome. Pediatr Nephrol 13:840-845
43. van de Kar NC, Sauerwein RW, Demacker PN, Grau GE, van Hinsbergh VW, Monnens LA 1995 Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71:309-313
44. Proulx F, Turgeon JP, Litalien C, Mariscalco MM, Robitaille P, Seidman E 1998 Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr Infect Dis J 17:899-904